Literature DB >> 15774801

Is there a new drug beyond floxuridine for intra-arterial hepatic chemotherapy in liver metastases from colorectal cancer?

G Fiorentini, S Rossi, P Bernardeschi, M Cantore, S Guadagni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774801     DOI: 10.1200/JCO.2005.99.297

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Intrahepatic therapy for liver-dominant metastatic colorectal cancer.

Authors:  Kerlijne De Groote; Hans Prenen
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

2.  Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach.

Authors:  Bert Hildebrandt; Maciej Pech; Annett Nicolaou; Jan M Langrehr; Jacek Kurcz; Birgit Bartels; Alexandra Miersch; Roland Felix; Peter Neuhaus; Hanno Riess; Bernd Dörken; Jens Ricke
Journal:  BMC Cancer       Date:  2007-04-24       Impact factor: 4.430

3.  Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study.

Authors:  Stefano Guadagni; Marco Clementi; Andrew R Mackay; Enrico Ricevuto; Giammaria Fiorentini; Donatella Sarti; Paola Palumbo; Panagiotis Apostolou; Ioannis Papasotiriou; Francesco Masedu; Marco Valenti; Aldo Victor Giordano; Gemma Bruera
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-22       Impact factor: 4.553

4.  Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study.

Authors:  Stefano Guadagni; Giammaria Fiorentini; Michele De Simone; Francesco Masedu; Odisseas Zoras; Andrew Reay Mackay; Donatella Sarti; Ioannis Papasotiriou; Panagiotis Apostolou; Marco Catarci; Marco Clementi; Enrico Ricevuto; Gemma Bruera
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-16       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.